{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:34Z","timestamp":1792783114437,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fondazione IEO-CCM","id":[{"id":"https:\/\/ror.org\/02yjmtx54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00384-020-03517-x","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T03:03:01Z","timestamp":1581130981000},"page":"685-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy"],"prefix":"10.1007","volume":"35","author":[{"given":"Veronica","family":"Dell\u2019Acqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Surgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Arculeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-9022","authenticated-orcid":false,"given":"Maria Alessia","family":"Zerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Simona","family":"Ravenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Saveria","family":"Rotundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatjona","family":"Kraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarek","family":"Kobiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Spychalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna Alessandra","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Bazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Petz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Glynne-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354\u2013356","journal-title":"Dis Colon Rectum"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/0360-3016(91)90265-6","volume":"21","author":"BJ Cummings","year":"1991","unstructured":"Cummings BJ, Keane TJ, O\u2019Sullivan B et al (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115\u20131125","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/BF02049397","volume":"35","author":"J Papillon","year":"1992","unstructured":"Papillon J, Chassard JL (1992) Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients. Dis Colon Rectum 35:422\u2013429","journal-title":"Dis Colon Rectum"},{"key":"3517_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","volume":"12","author":"HE Uronis","year":"2007","unstructured":"Uronis HE, Bendell JC (2007) Anal cancer: an overview. Oncologist 12:524\u2013534","journal-title":"Oncologist"},{"key":"3517_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.6004\/jnccn.2010.0008","volume":"8","author":"JM Pepek","year":"2010","unstructured":"Pepek JM, Willett CG, Czito BG (2010) Radiation therapy advances for treatment of anal cancer. J Natl Compr Cancer Netw 8:123\u2013129","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"3517_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ et al (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86(1):27\u201333","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","volume":"63","author":"MT Milano","year":"2005","unstructured":"Milano MT, Jani AB, Farrey KJ et al (2005) Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63:354\u2013361","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","volume":"37","author":"MP Mitchell","year":"2014","unstructured":"Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P (2014) Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Am J Clin Oncol 37:461\u2013466","journal-title":"Am J Clin Oncol"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","volume":"25","author":"JK Salama","year":"2007","unstructured":"Salama JK, Mell LK, Schomas DA et al (2007) Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25:4581\u20134586","journal-title":"J Clin Oncol"},{"issue":"2","key":"3517_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"5","key":"3517_CR11","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, Chu J et al (2012) Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys 83(5):1455\u20131462","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR12","unstructured":"ICRU Report 83. Prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT) (ICRU Report 83). International Commission on Radiation Units and Measurements, Bethesda, MD (2010)"},{"issue":"2","key":"3517_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-2-41","volume":"15","author":"C Menkarios","year":"2007","unstructured":"Menkarios C, Azria D, Lalibert\u00e9 B et al (2007) Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 15(2):41","journal-title":"Radiat Oncol"},{"issue":"13","key":"3517_CR14","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1002\/cncr.29337","volume":"121","author":"AN Viswanathan","year":"2015","unstructured":"Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK (2015) NRG oncology\/ RTOG 0921: a phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer. 121(13):2156\u20132163","journal-title":"Cancer."},{"key":"3517_CR15","unstructured":"Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). Common Terminology Criteria for Adverse Events (CTCAE): version 4.0. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda: Maryland; 2009. v4.02: 2009"},{"issue":"5","key":"3517_CR16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR17","unstructured":"Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. Wiley & Sons Ltd; 1980"},{"key":"3517_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1748-717X-7-201","volume":"7","author":"CV Dewas","year":"2012","unstructured":"Dewas CV, Maingon P, Dalban C et al (2012) Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer? Radiat Oncol 7:201","journal-title":"Radiat Oncol"},{"issue":"4","key":"3517_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00432-018-2608-6","volume":"144","author":"B De Bari","year":"2018","unstructured":"De Bari B, Lestrade L, Franzetti-Pellanda A et al (2018) Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients. J Cancer Res Clin Oncol 144(4):781\u2013789","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18_suppl","key":"3517_CR20","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1200\/jco.2006.24.18_suppl.4009","volume":"24","author":"JA Ajani","year":"2006","unstructured":"Ajani JA, Winter KA, Gunderson LL et al (2006) Intergroup RTOG 98\u201311: a phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 24(18_suppl):4009\u20134009","journal-title":"J Clin Oncol"},{"key":"3517_CR21","first-page":"39","volume":"6","author":"M Chuong","year":"2013","unstructured":"Chuong M, Freilich J, Hoffe S, Fulp W, Weber JM, Almhanna K, Dinwoodie W, Rao N, Meredith KL, Shridhar R (2013) Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Gastrointest Cancer Res 6:39\u201345","journal-title":"Gastrointest Cancer Res"},{"issue":"5","key":"3517_CR22","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.ijrobp.2010.07.1995","volume":"81","author":"R Glynne-Jones","year":"2011","unstructured":"Glynne-Jones R, Sebag-Montefiore D, Adams R et al (2011) \u201cMind the gap\u201d\u2014the impact of variations in the duration of the treatment gap and overall treatment time in the first UK anal cancer trial (act I). Int J Radiation Oncology Biol Phys 81(5):1488\u20131494","journal-title":"Int J Radiation Oncology Biol Phys"},{"issue":"34","key":"3517_CR23","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","volume":"28","author":"E Ben-Josef","year":"2010","unstructured":"Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock J, Myerson R, Anne R, Rosenthal SA, Willett C (2010) Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of radiation therapy oncology group trials 87-04 and 98-11. J Clin Oncol 28(34):5061\u20135066","journal-title":"J Clin Oncol"},{"key":"3517_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12032-018-1118-3","volume":"35","author":"V Dell\u2019Acqua","year":"2018","unstructured":"Dell\u2019Acqua V, Kobiela J, Kraja F et al (2018) Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT. Med Oncol 35:59","journal-title":"Med Oncol"},{"issue":"5","key":"3517_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2010.04.011","volume":"80","author":"AM Chen","year":"2011","unstructured":"Chen AM, Farwell DG, Luu Q et al (2011) Marginal misses after post- operative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 80(5):1423\u20131429","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3517_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13014-016-0628-4","volume":"4","author":"J Koeck","year":"2016","unstructured":"Koeck J, Lohr F, Buergy D et al (2016) Genital invasion or perigenital spread may pose a risk of marginal misses for intensity modulated radiotherapy (IMRT) in anal cancer. Radiat Oncol 4(11):53","journal-title":"Radiat Oncol"},{"issue":"1","key":"3517_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/COC.0000000000000009","volume":"39","author":"JA Call","year":"2016","unstructured":"Call JA, Prendergast BM, Jensen LG et al (2016) Intensity-modulated radiation therapy for anal cancer: results from a multi-institutional retrospective cohort study. Am J Clin Oncol 39(1):8\u201312","journal-title":"Am J Clin Oncol"},{"key":"3517_CR28","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1002\/cncr.25901","volume":"117","author":"JG Bazan","year":"2011","unstructured":"Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, Welton ML, Shelton A, Kapp DS, Koong AC, Goodman KA, Chang DT (2011) Intensity modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 117:3342\u20133351","journal-title":"Cancer."},{"issue":"8","key":"3517_CR29","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","volume":"25","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Kadalayil L, Meadows HM, Cunningham D, Samuel L, Geh JI, Lowdell C, James R, Beare S, Begum R, Ledermann JA, Sebag-Montefiore D, ACT II Study Group (2014) Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial. Ann Oncol 25(8):1616\u20131622","journal-title":"Ann Oncol"},{"issue":"3","key":"3517_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.radonc.2018.08.008","volume":"129","author":"JC Faivre","year":"2018","unstructured":"Faivre JC, Peiffert D, Vendrely V, Lemanski C, Hannoun-Levi JM, Mirabel X, Stanbury T, Salleron J, Guillemin F (2018) Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: a pooled analysis of two prospective trials (KANAL 2 and ACCORD 03). Radiother Oncol 129(3):463\u2013470","journal-title":"Radiother Oncol"},{"issue":"29","key":"3517_CR31","doi-asserted-by":"publisher","first-page":"20439","DOI":"10.18632\/oncotarget.24926","volume":"9","author":"A Hosni","year":"2018","unstructured":"Hosni A, Han K, Le Lisa W et al (2018) The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy. Oncotarget. 9(29):20439\u201320450","journal-title":"Oncotarget."},{"issue":"4","key":"3517_CR32","first-page":"205","volume":"2","author":"M John","year":"1996","unstructured":"John M, Pajak T, Flam M et al (1996) Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 2(4):205\u2013211","journal-title":"Cancer J Sci Am"},{"issue":"6","key":"3517_CR33","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3109\/0284186X.2015.1124141","volume":"55","author":"NB Tomasoa","year":"2016","unstructured":"Tomasoa NB, Meulendijks D, Nijkamp J, Cats A, Dewit L (2016) Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal. Acta Oncol 55(6):760\u2013766","journal-title":"Acta Oncol"},{"issue":"3","key":"3517_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/ajco.12768","volume":"14","author":"F Arcadipane","year":"2018","unstructured":"Arcadipane F, Franco P, Ceccarelli M et al (2018) Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer. Asia Pac J Clin Oncol 14(3):217\u2013223","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"3517_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13014-018-1124-9","volume":"13","author":"P Franco","year":"2018","unstructured":"Franco P, De Bari B, Arcadipane F et al (2018) Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study. Radiat Oncol 13(1):172","journal-title":"Radiat Oncol"},{"key":"3517_CR36","first-page":"515","volume":"85","author":"JE Dalby","year":"1961","unstructured":"Dalby JE, Pointon RS (1961) The treatment of anal carcinoma by interstitial irradiation. Am J Roentgenol Radium Therapy, Nucl Med 85:515\u2013520","journal-title":"Am J Roentgenol Radium Therapy, Nucl Med"},{"issue":"3","key":"3517_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.brachy.2007.02.152","volume":"6","author":"C Oehler-J\u00e4nne","year":"2007","unstructured":"Oehler-J\u00e4nne C, Seifert B, L\u00fctolf UM et al (2007) Clinical outcome after treatment with brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy. 6(3):218\u2013226","journal-title":"Brachytherapy."},{"issue":"3","key":"3517_CR38","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.ijrobp.2012.09.034","volume":"85","author":"L Moureau-Zabotto","year":"2013","unstructured":"Moureau-Zabotto L, Ortholan C, Hannoun-Levi JM et al (2013) Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study). Int J Radiat Oncol Biol Phys 85(3):e135\u2013e142","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3517_CR39","first-page":"218","volume":"5","author":"P Niehoff","year":"2014","unstructured":"Niehoff P, Kov\u00e1cs G (2014) HDR brachytherapy for anal cancer. J Gastrointest Oncol 5(3):218\u2013222","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"3517_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3322\/caac.21259","volume":"65","author":"R Shridhar","year":"2015","unstructured":"Shridhar R, Shibata D, Chan E et al (2015) Anal cancer: current standards in care and recent changes in practice. CA Cancer J Clin 65(2):139\u2013162","journal-title":"CA Cancer J Clin"},{"key":"3517_CR41","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA et al (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol 30:4344\u20134351","journal-title":"J Clin Oncol"},{"key":"3517_CR42","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM et al (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial. Lancet Oncol 14:516\u2013524","journal-title":"Lancet Oncol"},{"key":"3517_CR43","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ijrobp.2017.03.022","volume":"98","author":"KA Goodman","year":"2017","unstructured":"Goodman KA, Julie D, Cercek A et al (2017) Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive Chemoradiation using intensity modulated radiation therapy for anal Cancer. Int J Radiat Oncol Biol Phys 98:1087\u20131095","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","volume":"72","author":"R Glynne-Jones","year":"2008","unstructured":"Glynne-Jones R, Meadows H, Wan S et al (2008) EXTRA-A multicenter phase II study of Chemoradiation using a 5 day per week Oral regimen of capecitabine and intravenous mitomycin C in anal Cancer. Int J Radiat Oncol Biol Phys 72:119\u2013126","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1748-717X-9-124","volume":"9","author":"G Thind","year":"2014","unstructured":"Thind G, Johal B, Follwell M et al (2014) Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma. Radiat Oncol 9:124","journal-title":"Radiat Oncol"},{"key":"3517_CR46","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ijrobp.2018.04.033","volume":"101","author":"CM Jones","year":"2018","unstructured":"Jones CM, Adams R, Downing A et al (2018) Toxicity, tolerability, and compliance of concurrent capecitabine or 5-fluorouracil in radical management of anal cancer with single-dose mitomycin-C and intensity modulated radiation therapy: evaluation of a national cohort. Int J Radiat Oncol Biol Phys 101:1202\u20131211","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3517_CR47","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1002\/cncr.28296","volume":"119","author":"C Eng","year":"2013","unstructured":"Eng C, Chang GJ, You YN et al (2013) Long-term results of weekly\/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119:3769","journal-title":"Cancer"},{"key":"3517_CR48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3332\/ecancer.2016.699","volume":"10","author":"K Souza","year":"2016","unstructured":"Souza K, Pereira A, Araujo R et al (2016) Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis. Ecancermedicalscience. 10:699","journal-title":"Ecancermedicalscience."},{"issue":"10","key":"3517_CR49","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","volume":"40","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 40(10):1165\u20131176","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"3517_CR50","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cam4.1203","volume":"6","author":"M Repka","year":"2017","unstructured":"Repka M, Aghdam N, Karlin A et al (2017) Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting. Cancer Med 6(11):2497\u20132506","journal-title":"Cancer Med"},{"issue":"22","key":"3517_CR51","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1002\/cncr.31721","volume":"124","author":"JK Elson","year":"2018","unstructured":"Elson JK, Kachnic LA, Kharofa JR (2018) Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: a National Cancer Data Base Study. Cancer. 124(22):4383\u20134392","journal-title":"Cancer."},{"key":"3517_CR52","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase II randomized intergroup study. J Clin Oncol 14:2526\u20132539","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-020-03517-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:23:56Z","timestamp":1612823036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-020-03517-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03517-x","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,8]]},"assertion":[{"value":"26 January 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (research project entitled \u201cImage guided radiotherapy in gastrointestinal malignancies\u201d notified to the Ethical Committee of the IEO, Milan, Italy No. IEO N87\/11) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}